For prostate cancer-associated rs7077275 [154], the risk allele enhances CTCF binding and enhances the allele-specific expression of CTBP2 [155], which decreases the apoptosis of prostate cancer cells and increases tumor growth in a mouse xenograft model of human prostate cancer [156]. Here, CTCF is linked to prostate carcinoma.